Dare Bioscience, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price
Dare Bioscience, Inc. (DARE) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price of $31.40 per share as of 2017-12-31, per its 10-K filed 2018-03-28.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice · last filed 2018-03-28
- 2017-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $31.40.
- 2017-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $0.00; Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price as first filed $40.10.
- 2017-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $3.56.
- 2016-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $0.00; Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price as first filed $4.33.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price as first filed |
|---|---|---|
| 2017-12-31 | $31.40 10-K · filed 2018-03-28 | |
| 2017-06-30 | $0.00 8-K/A · filed 2017-10-02 | $40.10 10-Q · filed 2017-08-14 |
| 2017-03-31 | $3.56 10-Q · filed 2017-05-12 | |
| 2016-12-31 | $0.00 8-K/A · filed 2017-10-02 | $4.33 10-K · filed 2017-03-31 |
| 2016-09-30 | $4.31 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $4.57 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $4.79 10-Q · filed 2016-05-02 | |
| 2015-12-31 | $5.32 10-K · filed 2016-03-10 | |
| 2015-09-30 | $6.52 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $6.50 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $7.14 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $5.46 10-K · filed 2015-03-19 | |
| 2014-09-30 | $5.71 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $5.72 10-Q · filed 2014-08-12 | |
| 2014-03-31 | $5.62 10-Q · filed 2014-05-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |